Literature DB >> 21885497

High risk of ischemic heart disease in patients with lupus nephritis.

Mikkel Faurschou1, Lene Mellemkjaer, Henrik Starklint, Anne-Lise Kamper, Ulrik Tarp, Anne Voss, Søren Jacobsen.   

Abstract

OBJECTIVE: To investigate the occurrence of ischemic heart disease (IHD) in a cohort of 104 Danish patients with biopsy-proven lupus nephritis (LN).
METHODS: Information on all hospitalizations in Denmark for IHD between 1977 and 2006 was obtained from the Danish National Hospital Register. Occurrence of IHD after date of first renal biopsy in the LN cohort was compared to the occurrence of IHD in the general population by calculation of standardized ratios of observed to expected events (O:E ratios) for different manifestations of IHD registered during inpatient and outpatient hospital visits.
RESULTS: The median duration of followup was 14.7 (range 0.1-30.0) years. Thirty-one first-time hospitalizations for IHD occurred in the cohort, yielding an overall O:E ratio for IHD of 6.8 (95% CI 4.6-9.7). Increased risks were found for angina pectoris (O:E ratio 6.0, 95% CI 3.0-11), myocardial infarction (O:E ratio 7.9, 95% CI 3.8-15), and other IHD-related diagnoses combined (O:E ratio 6.9, 95% CI 3.3-13). A high IHD risk was observed for patients aged < 31 years at time of first renal biopsy (O:E ratio 17.1, 95% CI 9.1-29) and for patients aged 30-39 years during followup (O:E ratio 42.3, 95% CI 21-76). Patients undergoing chronic renal replacement therapy also had a pronounced risk of IHD (O:E ratio 19.4, 95% CI 7.8-40).
CONCLUSION: LN is associated with markedly increased morbidity from IHD. Our findings indicate that patients with early-onset LN have a disturbingly high risk of IHD compared to the general population.

Entities:  

Mesh:

Year:  2011        PMID: 21885497     DOI: 10.3899/jrheum.110329

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

Review 1.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

2.  Lipid Testing and Statin Prescriptions Among Medicaid Recipients With Systemic Lupus Erythematosus or Diabetes Mellitus and the General Medicaid Population.

Authors:  Sarah K Chen; Medha Barbhaiya; Michael A Fischer; Hongshu Guan; Tzu-Chieh Lin; Candace H Feldman; Brendan M Everett; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-01       Impact factor: 4.794

3.  Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.

Authors:  Johanna T Gustafsson; Marie Herlitz Lindberg; Iva Gunnarsson; Susanne Pettersson; Kerstin Elvin; John Öhrvik; Anders Larsson; Kerstin Jensen-Urstad; Elisabet Svenungsson
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

4.  Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.

Authors:  Holly L Hutton; Adeera Levin; Jagbir Gill; Ognjenka Djurdjev; Mila Tang; Sean J Barbour
Journal:  BMC Nephrol       Date:  2017-03-20       Impact factor: 2.388

5.  Association of Lupus Nephritis With Coronary Artery Disease by ISN/RPS Classification: Results From a Large Real-world Lupus Population.

Authors:  Enid Y Sun; Carolina Alvarez; Saira Z Sheikh
Journal:  ACR Open Rheumatol       Date:  2019-05-28

6.  MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor.

Authors:  Na Wang; Lishu He; Hui Lin; Lunbo Tan; Yuan Sun; Xiaoying Zhang; A H Jan Danser; Hong S Lu; Yongcheng He; Xifeng Lu
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

7.  Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis.

Authors:  Jinoos Yazdany; Nick Pooley; Julia Langham; Lindsay Nicholson; Sue Langham; Nina Embleton; Xia Wang; Barnabas Desta; Volkan Barut; Edward Hammond
Journal:  RMD Open       Date:  2020-09

8.  A Systematic Review and Meta-analysis of Prevalence of Biopsy-Proven Lupus Nephritis.

Authors:  Hong Wang; Yi-le Ren; Jun Chang; Luo Gu; Ling-Yun Sun
Journal:  Arch Rheumatol       Date:  2017-07-25       Impact factor: 1.472

9.  Asymptomatic Carotid Atherosclerosis Cardiovascular Risk Factors and Common Hypertriglyceridemia Genetic Variants in Patients with Systemic Erythematosus Lupus.

Authors:  Marta Fanlo-Maresma; Beatriz Candás-Estébanez; Virginia Esteve-Luque; Ariadna Padró-Miquel; Francesc Escrihuela-Vidal; Monica Carratini-Moraes; Emili Corbella; Xavier Corbella; Xavier Pintó
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

10.  Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study.

Authors:  Isak Samuelsson; Ioannis Parodis; Iva Gunnarsson; Agneta Zickert; Claes Hofman-Bang; Håkan Wallén; Elisabet Svenungsson
Journal:  Lupus Sci Med       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.